46 XY disorder of sex development (DSD) due to 5 alpha (SRD5A2) deficiency – Experience from a multidisciplinary Pediatric Gender Clinic



      SRD5A2 deficiency leads to incomplete masculinization of individuals with a 46 XY karyotype. A definitive diagnosis in early infancy facilitates decisions concerning choice of sex of rearing and management.


      To review the clinical presentation, diagnosis, treatment and outcome of children with 46 XY DSD due to SRD5A2 deficiency at a Paediatric Gender Clinic.

      Study design and methods

      Retrospective review of cases of SRD5A2 deficiency (2000–15) managed with a standard protocol at a multidisciplinary clinic. Demographic data, clinical presentation, physical findings, investigations (hormonal profile, imaging, genitoscopy), psychological evaluation (child, family), medical and surgical management, outcome and follow up were collated and analyzed.


      There were 12 cases aged 3 days–14 years at presentation, 3 had parental consanguinity. Eight were reared as males and 4 as females. Specialist referral was sought for hypospadias (5), atypical genitalia (5) or incongruent pubertal masculinization (2). All had chordee, symmetrical inguinoscrotal gonads, rugose labioscrotum and proximal hypospadias (perineoscrotal −9, perineal −3). Both pubertal cases had significant masculinization and no gynecomastia. The median testosterone/dihydrotestosterone ratio was 22.1(IQR-8.6-55.7). Despite a classical phenotype, four (2 prepubertal, 2 pubertal) had a ratio <10. Genitoscopy showed urogenital sinus remnant (4) and hypoplastic verumontanum (5). Sex reassignment was done in 4. Surgical management was staged and completed by 4 years in those with infantile presentation. Besides correction of chordee and urethroplasty in 11, other procedures included orchidopexy (5), excision of a urogenital sinus remnant (4) and correction of penoscrotal transposition (4). The urethroplasty was single staged in 3. All operated cases were followed up (mean age at last follow up - 10.63 years, mean follow up period - 7.25 years). The overall cosmetic result was satisfactory, but the phallic structure remained relatively small across prepubertal period. Uroflowmetry curves were normal in 9. All showed penile tumescence/erection and two peripubertal cases had typical secondary sexual characters. All cases, including those with sex reassignment, have a well-adjusted male psyche.

      Discussion and conclusion

      The diagnosis, management and longitudinal follow up of cases of SRD5A2 deficiency at a multidisciplinary gender clinic is presented. Diagnostic dilemmas with low T/DHT ratios remained in a third of cases. Most were diagnosed in infancy and assigned a male sex of rearing, all underwent staged masculinizing genitoplasty. Those with sex reassignment also fared well with comprehensive management after family counseling.



      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hughes I.A.
        • Houk C.
        • Ahmed S.F.
        • Lee P.A.
        LWPES/ESPE Consensus Group. Consensus statement on management of intersex disorders.
        Arch Dis Child. 2006; 91: 554-563
        • Pieretti R.V.
        • Donahue P.K.
        Disorders of sexual development.
        in: Coran A.G. Adzick N.S. Kermonel T.M. Laberge J.M. Caldamme A. Shamberger R. Pediatric surgery. 7 th Edition. Elsevier, Philadelphia2006: 1565-1590
        • Byers H.M.
        • Mohnach L.H.
        • Fechner P.Y.
        • Chen M.
        • Thomas I.H.
        • Ramsdell L.A.
        • et al.
        Unexpected ethical dilemmas in sex assignment in 46,XY DSD due to 5-alpha reductase type 2 deficiency.
        Am J Med Genet C Semin Med Genet. 2017; 175: 260-267
        • Imperato-McGinley J.
        • Guerrero L.
        • Gautier T.
        • Peterson R.E.
        Steroid 5a-reductase deficiency in man: an inherited form of male pseudohermaphroditism.
        Science. 1974; 186: 1213-1215
        • Sinnecker G.H.
        • Hiort O.
        • Dibbelt L.
        • Albers N.
        • Dörr H.G.
        • Hauss H.
        • et al.
        Phenotypic classification of male pseudohermaphroditism due to steroid 5-reductase 2 deficiency.
        Am J Med Genet. 1996; 63: 223-230
        • Ahmed S.F.
        • Khwaja O.
        • Hughes I.A.
        The role of a clinical score in the assessment of ambiguous genitalia.
        BJU Int. 2000; 85: 120-124
        • Chan Y.M.
        • Hannema S.E.
        • Achermann J.C.
        Hughes disorders of sex development.
        in: Melmed S. Koenig R.J. Auchus R.T. Rosen C.J. Goldfine A.B. Williams textbook of Endocrinology. 14 th Edition. Elsevier, Philadelphia2020: 867-936
        • Nn-Junior Veiga
        • Medaets P.A.R.
        • Petroli R.J.
        • Calais F.L.
        • de Mello M.P.
        • de Sousa Castro C.C.T.
        • et al.
        Clinical and laboratorial features that may differentiate 46,XY DSD due to partial androgen insensitivity and 5α-reductase type 2 deficiency.
        Internet J Endocrinol. 2012; 2012: 964876
        • DiSandro M.
        • Merke D.P.
        • Rink R.C.
        Review of current surgical techniques and medical management considerations in the treatment of pediatric patients with disorders of sex development.
        Horm Metab Res. 2015 5; 47: 321-328
        • Maimoun L.
        • Philibert P.
        • Cammas B.
        • Audran F.
        • Bouchard P.
        • Fenichel P.
        • et al.
        Phenotypical, biological, and molecular heterogeneity of 5 alpha- reductase deficiency: an extensive international experience of 55 patients.
        J Clin Endocrinol Metab. 2011; 96: 296-307
        • Shabir I.
        • Khurana M.L.
        • Joseph A.A.
        • Eunice M.
        • Mehta M.
        • Ammini A.C.
        Phenotype, genotype and gender identity in a large cohort of patients from India with 5a-reductase 2 deficiency.
        Andrology. 2015; 3: 1132-1139
        • Morel Y.
        • Rey R.
        • Teinturier C.
        • Nicolino M.
        • Michel-Calemard L.
        • Mowszowicz I.
        • et al.
        Aetiological diagnosis of male sex ambiguity: a collaborative study.
        Eur J Pediatr. 2002; 161: 49-59
        • Cohen-Kettenis P.T.
        Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency.
        Arch Sex Behav. 2005; 34: 399-410
        • Hackel C.
        • Oliveira L.E.C.
        • Ferraz L.F.C.
        • Tonini M.M.O.
        • Silva D.N.
        • Toralles M.B.
        • et al.
        New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2.
        J Mol Med (Berl). 2005; 83: 569-576
        • Nicoletti A.
        • Baldazzi L.
        • Balsamo A.
        • Barp L.
        • Pirazzoli P.
        • Gennari M.
        • et al.
        SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects.
        Clin Endocrinol. 2005; 63: 375-380
        • Canovatchel W.J.
        • Volquez D.
        • Huang S.
        • Wood E.
        • Lesser M.L.
        • Gautier T.
        • et al.
        Luteinizing hormone pulsatility in subjects with 5alpha -reductase deficiency and decreased dihydrotestosterone production.
        J Clin Endocrinol Metab. 1994; 78: 916-921
        • Chan A.O.
        • But B.W.
        • Lau G.T.
        • Lam A.L.
        • Ng K.L.
        • Lam Y.Y.
        • et al.
        Diagnosis of 5alpha-reductase 2 deficiency: a local experience.
        Hong Kong Med J. 2009; 15 (PMID: 19342739): 130-135
        • Bao A.M.
        • Swaab D.F.
        Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders.
        Front Neuroendocrinol. 2011; 32: 214-226
        • Martin C.L.
        • Ruble D.N.
        Patterns of gender development.
        Annu Rev Psychol. 2010; 61: 353-381
        • Coleman Eli
        • Bockting Walter
        • Botzer
        • et al.
        Standards of care for the Health of transsexual, transgender, and gender-nonconforming people.
        Int J Transgenderism. 2012; 13: 165-232
        • Money J.
        • Hampson J.G.
        • Hampson J.L.
        Hermaphroditism: recommendations concerning assignment of sex, change of sex and psychologic management.
        Bull Johns Hopkins Hosp. 1955; 97 (PMID: 13260819): 284-300
        • Bleier R.
        Why does a pseudohermaphrodite want to be a man?.
        N Engl J Med. 1979; 301: 839-840
        • Imperato-McGinley J.
        • Zhu Y.S.
        Gender and behavior in subjects with genetic defects in male sexual differentiation.
        Hormones, Brain, Behavior. 2002; 5: 303-345
        • Nascimento R.L.P.
        • de Andrade Mesquita I.M.
        • Gondim R.
        • Dos Apóstolos R.A.A.C.
        • Toralles M.B.
        • de Oliveira L.B.
        • et al.
        Gender identity in patients with 5-alpha reductase deficiency raised as females.
        J Pediatr Urol. 2018; 14: 419.e1-419.e6
        • Cocchetti C.
        • Ristori J.
        • Mazzoli F.
        • et al.
        5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature.
        J Endocrinol Invest. 2020; 43: 1131-1136
        • Kang H.J.
        • Imperato-McGinley J.
        • Zhu Y.S.
        • Rosenwaks Z.
        The effect of 5α-reductase-2 deficiency on human fertility.
        Fertil Steril. 2014; 101: 310-316
        • Imperato-McGinley J.
        • Zhu Y.S.
        Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency.
        Mol Cell Endocrinol. 2002; 198: 51-59
        • Heino F.L.
        • Meyer-Bahlburg
        Variants of gender differentiation in somatic disorders of sex development: recommendations for version 7 of the world professional association for transgender health's standards of care.
        Int J Transgenderism. 2009; 11: 226-237
        • Zucker K.J.
        Measurement of psychosexual differentiation.
        Arch Sex Behav. 2005; 34: 375-388
        • Sandberg D.E.
        • Gardner M.
        • Cohen-Kettenis P.T.
        Psychological aspects of the treatment of patients with disorders of sex development.
        Semin Reprod Med. 2012; 30: 443-452